GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 05/07/2011
PIL Tracrium Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 20/04/2011 and displayed until 05/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 19/03/2009 and displayed until 20/04/2011
Reasons for adding or updating:
  • Change to packaging
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change due to user-testing of patient information
Updated on 09/11/2007 and displayed until 19/03/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 28/02/2005 and displayed until 09/11/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 26/01/2004 and displayed until 28/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 15/05/2002 and displayed until 26/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 02/02/2001 and displayed until 15/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   atracurium besilate